Off-the-shelf vaccine shows early promise against pancreatic and colorectal cancer recurrence, with vaccine-induced immune responses correlating with longer cancer-free survival.
Treasury expands Fed chair search, with candidates holding diverse policy views on interest rates.
European firms launch share buyback programs to optimize capital structure and return value to shareholders.
Off-the-shelf vaccine shows early promise against pancreatic and colorectal cancer recurrence, with vaccine-induced immune responses correlating with longer cancer-free survival.
Treasury expands Fed chair search, with candidates holding diverse policy views on interest rates.
European firms launch share buyback programs to optimize capital structure and return value to shareholders.